Gregory E. Spurlock Net Worth

The estimated Net Worth of Gregory E. Spurlock is at least $1.12 Million dollars as of 17 June 2024. Gregory Spurlock owns over 14,334 units of Global X Funds stock worth over $89,804 and over the last 11 years Gregory sold AIQ stock worth over $1,028,085.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Gregory Spurlock AIQ stock SEC Form 4 insiders trading

Gregory has made over 3 trades of the Global X Funds stock since 2013, according to the Form 4 filled with the SEC. Most recently Gregory sold 14,334 units of AIQ stock worth $856,457 on 17 June 2024.

The largest trade Gregory's ever made was selling 14,334 units of Global X Funds stock on 17 June 2024 worth over $856,457. On average, Gregory trades about 1,510 units every 283 days since 2013. As of 17 June 2024 Gregory still owns at least 2,591 units of Global X Funds stock.

You can see the complete history of Gregory Spurlock stock trades at the bottom of the page.

What's Gregory Spurlock's mailing address?

Gregory's mailing address filed with the SEC is C/O RADNET, INC., 1510 COTNER AVENUE, LOS ANGELES, CA, 90025.

Insiders trading at Global X Funds

Over the last 21 years, insiders at Global X Funds have traded over $406,216,779 worth of Global X Funds stock and bought 11,973,300 units worth $47,156,496 . The most active insiders traders include Henry R Kravis, James H Jr Greene, and Alexandar Jrraether Paul Er.... On average, Global X Funds executives and independent directors trade stock every 92 days with the average trade being worth of $57,648,557. The most recent stock trade was executed by Rhonda A Longmore Grund on 19 May 2016, trading 2,500 units of AIQ stock currently worth $18,975.

What does Global X Funds do?

Complete history of Gregory Spurlock stock trades at Radnet Inc and Global X Funds

Global X Funds executives and stock owners

Global X Funds executives and other stock owners filed with the SEC include:

• R Brian Hanson,
  Executive VP & CFO
• Russell D Jr Phillips,
  EVP, Gen.Coun.,Secre.
• Henry R Kravis,
  Director
• Kenneth S Ord,
  Executive VP & CFO
• Rhonda A Longmore Grund,
  EVP and CFO
• Heping Feng,
  
• Tao L. Zhang,
  
• Edward L Samek,
  Director
• Richard A. Jones,
  Executive Vice President
• Neil F Dimick,
  Director
• Paul S Viviano,
  Chairman, President & CEO
• Richard W Johns,
  EVP, General Counsel & Sec.
• Percy C Jr Tomlinson,
  President & CEO
• Gregory E. Spurlock,
  President. Alliance Oncology
• Christianna S Rosow,
  Principal Accounting Officer
• Scott A Bartos,
  Director
• Larry C. Buckelew,
  Director
• Howard K Aihara,
  VP & Corporate Controller
• Deborah Rodriguez,
  EVP, Human Resources
• Michael J Shea,
  Chief Operating Officer
• Nicholas A Poan,
  VP, Corporate Controller
• Eli H Glovinsky,
  Exec.VP,Gen.Coun,Corp.Secre.
• Michael F Frisch,
  Executive Vice President & COO
• Richard J Hall,
  President, Alliance Oncology
• Curtis Lane,
  Director
• Christopher J Joyce,
  Executive Vice President, M&A
• Aaron Bendikson,
  Director
• Health Investors Ii, Lp All...,
  
• Anthony B Helfet,
  Director
• Principal Opportunities Fun...,
  
• Michael P Harmon,
  Director
• Health Investors Ii, Lp All...,
  
• Alexandar Jrraether Paul Er...,
  
• James C Momtazee,
  Director
• Michael W Michelson,
  Director
• Kenneth W/Nj Freeman,
  Director
• 1996 Gp Llckkr Associates 1...,
  
• James H Jr Greene,
  Director
• Adam Clammer,
  Director
• Andrew P Hayek,
  Executive VP & COO